Judith W M Jeuken - JoVE Visualize

Showing results (11-20 of 22) with videos related to

Pageof 3

Sort By:

Brain Pathology (Zurich, Switzerland)|October 30, 2010

The nature and timing of specific copy number changes in the course of molecular progression in diffuse gliomas: further elucidation of their genetic "life story"Judith W M Jeuken, Angelique Sijben, Fonnet E Bleeker, et al.

Laboratory Investigation; a Journal of Technical Methods and Pathology|August 19, 2007

MS-MLPA: an attractive alternative laboratory assay for robust, reliable, and semiquantitative detection of MGMT promoter hypermethylation in gliomasJudith W M Jeuken, Sandra J B Cornelissen, Martine Vriezen, et al.

Pediatric Blood & Cancer|September 18, 2010

Taqman genotyping assays can be used on decalcified and paraffin-embedded tissue from patients with osteosarcomaMelanie M Hagleitner, Marieke J H Coenen, Judith W M Jeuken, et al.

Journal of Cancer Research and Clinical Oncology|December 20, 2022

Biomarker concordance between primary colorectal cancer and ovarian metastases: a Dutch cohort studyRichard van der Meer, Judith W M Jeuken, Steven L Bosch, et al.

Journal of Neurosurgery|October 31, 2002

Analysis of von hippel-lindau mutations with comparative genomic hybridization in sporadic and hereditary hemangioblastomas: possible genetic heterogeneityJohanna M M Gijtenbeek, Bram Jacobs, Sandra H E Sprenger, et al.

Analytical Chemistry|October 18, 2013

Multiplex blood reporters for simultaneous monitoring of cellular processesM Sarah S Bovenberg, M Hannah Degeling, Seyedali Hejazi, et al.

Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 18, 2007

Chromosomal and methylation alterations in sporadic and familial adenomatous polyposis-related duodenal carcinomasMarloes Berkhout, Iris D Nagtegaal, Sandra J B Cornelissen, et al.

Acta Neuropathologica|June 26, 2009

Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomasChristian Hartmann, Jochen Meyer, Jörg Balss, et al.

Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 23, 2013

Significance of complete 1p/19q co-deletion, IDH1 mutation and MGMT promoter methylation in gliomas: use with cautionSandra H E Boots-Sprenger, Angelique Sijben, Jos Rijntjes, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 11, 2009

MGMT promoter methylation is prognostic but not predictive for outcome to adjuvant PCV chemotherapy in anaplastic oligodendroglial tumors: a report from EORTC Brain Tumor Group Study 26951Martin J van den Bent, Hendrikus J Dubbink, Marc Sanson, et al.

Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:

Pageof 3

Brain Pathology (Zurich, Switzerland)|October 30, 2010

The nature and timing of specific copy number changes in the course of molecular progression in diffuse gliomas: further elucidation of their genetic "life story"Judith W M Jeuken, Angelique Sijben, Fonnet E Bleeker, et al.

Laboratory Investigation; a Journal of Technical Methods and Pathology|August 19, 2007

MS-MLPA: an attractive alternative laboratory assay for robust, reliable, and semiquantitative detection of MGMT promoter hypermethylation in gliomasJudith W M Jeuken, Sandra J B Cornelissen, Martine Vriezen, et al.

Pediatric Blood & Cancer|September 18, 2010

Taqman genotyping assays can be used on decalcified and paraffin-embedded tissue from patients with osteosarcomaMelanie M Hagleitner, Marieke J H Coenen, Judith W M Jeuken, et al.

Journal of Cancer Research and Clinical Oncology|December 20, 2022

Biomarker concordance between primary colorectal cancer and ovarian metastases: a Dutch cohort studyRichard van der Meer, Judith W M Jeuken, Steven L Bosch, et al.

Journal of Neurosurgery|October 31, 2002

Analysis of von hippel-lindau mutations with comparative genomic hybridization in sporadic and hereditary hemangioblastomas: possible genetic heterogeneityJohanna M M Gijtenbeek, Bram Jacobs, Sandra H E Sprenger, et al.

Analytical Chemistry|October 18, 2013

Multiplex blood reporters for simultaneous monitoring of cellular processesM Sarah S Bovenberg, M Hannah Degeling, Seyedali Hejazi, et al.

Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 18, 2007

Chromosomal and methylation alterations in sporadic and familial adenomatous polyposis-related duodenal carcinomasMarloes Berkhout, Iris D Nagtegaal, Sandra J B Cornelissen, et al.

Acta Neuropathologica|June 26, 2009

Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomasChristian Hartmann, Jochen Meyer, Jörg Balss, et al.

Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 23, 2013

Significance of complete 1p/19q co-deletion, IDH1 mutation and MGMT promoter methylation in gliomas: use with cautionSandra H E Boots-Sprenger, Angelique Sijben, Jos Rijntjes, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 11, 2009

MGMT promoter methylation is prognostic but not predictive for outcome to adjuvant PCV chemotherapy in anaplastic oligodendroglial tumors: a report from EORTC Brain Tumor Group Study 26951Martin J van den Bent, Hendrikus J Dubbink, Marc Sanson, et al.

Pageof 3